Results 71 to 80 of about 1,695,530 (119)

Neutropenia and infectious events during off-label treatment with venetoclax in children with malignant disease: a pharmacovigilance analysis of FDA adverse event reporting system reports. [PDF]

Ann Hematol
Muratore E, Giunchi V, Fusaroli M, Baccelli F, Gottardi F, Poluzzi E, Masetti R, Raschi E.   +7 more
europepmc   +1 more source

Venetoclax in Combination With Chemo-Immunotherapy in Richter Transformation: A Real-Life Experience. [PDF]

Hematol Oncol
Ballotta L, Olivieri J, Facchinelli D, Ferrarini I, Visentin A, Moia R, Cavallari M, Innao V, Derenzini E, Nierychlewska PM, Cuda A, Gattei V, Ballerini M, Lucchini E, Turoldo M, Rossetti MC, Gaudio F, Zaja F.   +17 more
europepmc   +1 more source

Covalent Targeting and Thermostabilization of Oncogenic R280K and R273H Mutants p53 by Small Molecule RVJB59. [PDF]

ChemMedChem
Ferreira RJF, Gonçalves LM, Mori M, Antunes AMM, Leandro AP, Santos MMM.   +5 more
europepmc   +1 more source

Anti-CD123 CAR-T therapy combined with autologous SCT and venetoclax maintenance in refractory BPDCN ineligible for allogeneic transplantation: a case report and review of the literature. [PDF]

Front Immunol
Yang F, Li D, Lei Y, Liu R, Fu Z, Ma L, Deng B, Ke X, Hu K.   +8 more
europepmc   +1 more source

Switchable organocatalytic enantioselective sulfenocyclization of cyclohexadienes enabling chemodivergent access to chiral bicyclo[m.n.1] ring systems. [PDF]

Nat Commun
Zhang BQ, Chen L, Xiao WY, Liu Y, Li YL, Deng J.   +5 more
europepmc   +1 more source

Re-treatment of relapse in elderly AML with time-limited venetoclax-based regimen: a case report and literature review. [PDF]

Ann Hematol
Ng JY, Gullapalli V, Othman J, Talaulikar D.   +3 more
europepmc   +1 more source

"Cut-and-Sew" Reactions of β-Lactams via C-C Bond Activation. [PDF]

J Am Chem Soc
Kan L, Zhang R, Lu SL, Hari Y, Dong G.
europepmc   +1 more source

Synthesis of Bicyclo[2.1.0]pentanes and Vinylcyclopropanes Using Palladium Carbenes: Ligand-Controlled Carbene Reactivity. [PDF]

J Am Chem Soc
Eckart-Frank IK, Arnold ES, Murphy LP, Wilkerson-Hill SM.   +3 more
europepmc   +1 more source

Pathway economy in cyclization of 1<i>,n</i>-enynes. [PDF]

Beilstein J Org Chem
Han H, Mao W, Lin B, Cheng M, Yang L, Liu Y.   +5 more
europepmc   +1 more source

Venetoclax and azacitidine for younger acute myeloid leukemia patients independent of fitness for intensive chemotherapy. [PDF]

Haematologica
Watts J, Madarang E, Abbott D, Hart P, Sohalski C, Zoso A, Dell-Martin J, Belachew A, Amaya ML, Kent A, McMahon C, Schwartz M, Sekeres MA, Smith C, Bradley T, Taylor J, Chandhok N, Venugopal S, Jordan C, Berg M, Haag M, Willard N, Aisner D, Schowinsky J, Pan Z, Zhang J, Gutman JA, Pollyea DA.   +27 more
europepmc   +1 more source